Skip to main content
. 2020 Nov 6;35(Suppl 2):ii35–ii46. doi: 10.1093/heapol/czaa127

Table 3.

Summary of methods and data sources

Method Stage of results chain Purpose Data sources Example finding
Process tracking All, except impact. Monitored fidelity of programme activities and outputs against ToC to identify successes and challenges during programme implementation
  • Meeting observation of EPI technical working group and other key meetings, increasingly structured over time (e.g. using structured checklists)

  • Document review of Gavi grant applications, budgets and performance frameworks (i.e. M&E frameworks), EPI policies, plans and strategies, published literature

  • Vaccines doses administered from HMIS

  • Fact checking interviews to clarify whether something occurred, to facilitate description of the process

  • In-depth interviews to understand why and how the processes unfolded as observed

See the 2016 cross-country report for how years of process tracking was used to explain years of HSS grant implementation delays across FCE countries (Gavi Full Country Evaluations Team, 2017)
RCA All, except impact.

Generates and tests hypotheses about the underlying causes of key programme success and challenges against all available evidence

Synthesizes relevant evidence for developing key findings and recommendations

Desk review, key informant and fact-checking interviews, analysis of HMIS data See Figure 4 for an example related to the sub-optimal coverage of new vaccines in Mozambique
Small-area estimates of vaccine coverage Outcomes Improve granularity of estimates of vaccine coverage in FCE countries to inform recommendations for resource targeting Household surveys Small-area estimates identified sub-national inequalities in each country
Observational study of determinants and constraints of effective vaccine coverage (Phillips et al., 2018) Outputs to outcomes Identify determinants of effective vaccine coverage to inform recommendations for improvement
  • Household surveys with linked sero-surveys and health facility surveys

  • Systematic review

See Phillips et al., 2018for estimates of the relative contribution of household and health systems determinants of the probability of a child being vaccinated
Resource tracking Inputs Estimate national resource envelopes and sources
  • Document review

  • KIIs

Resource tracking results were reported in 2016 country reports and paved the way for further analyses of fiscal space and financing scenarios in 2017
Partnership/network analysis Any (but primarily inputs to activities) Evaluate the effectiveness, efficiency and country ownership of national immunization partnerships and their contribution programme performance
  • Social network surveys

  • Document review

  • In-depth interviews

We analysed the structure and composition of the Uganda HPV vaccine introduction partners’ network to explain successes and challenges observed during decision-making around HPV vaccine (Kamya et al., 2016)
Vaccine effectiveness study Impact Estimate the impact of pneumococcal conjugate vaccine (PCV)
  • Nasopharyngeal carriage surveys

  • Disease surveillance

Together, these studies provided strong evidence of the effectiveness and impact of PCV10 on nasopharyngeal carriage of vaccine-type pneumococcus and the incidence of vaccine-type invasive pneumococcal disease and pneumonia (Gavi Full Country Evaluations Team, 2017)
Regression analyses Impact Estimate the impact of new vaccine introductions of PCV and rotavirus vaccines on child mortality
  • Household surveys

Our analyses indicate that high coverage of new vaccines is associated with significant improvements in child mortality. In 2016, there were 10.1% (95% UI: 6.4, 13.8) and 11.9% (95% UI: 9.4, 14.3) reductions in under-5 mortality in Mozambique and Zambia, respectively, compared with scenarios where these vaccines were not introduced (Gavi Full Country Evaluations Team, 2017)
District case studies (Phase 2) Inputs to activities to outputs to outcomes Identify the drivers of district performance
  • HMIS data

  • Document review

  • In-depth interviews with district managers and health workers

District case studies identified barriers and enablers of vaccine coverage; see e.g. Uganda’s 2017–18 report (Gavi Full Country Evaluations Team, 2018)